Pretreatment neurocognitive function (NCF) status in head and neck cancer (HNC) patients (pts) with comparison to control cohort. This is an ASCO Meeting Abstract from the 2012 ASCO Annual Meeting I.
Head and neck cancers (HNCs) are in general treated with conventional fractionation regimen of 1.8-2 Gy per fraction. Altered fractionation (ALFT) strategies such as hypofractionation radiotherapy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results